Tender Details

Country: Czech Republic
Summary: Lp for the Treatment of Pulmonary Arterial Hypertension (Pah) Xiii.
CZT Ref No: 122492429
Deadline: 12 Aug 2025
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: CZK 24770000
Notice Type: Tender
Document Ref. No.: 452816-2025
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
The subject of the public contract is the supply of medicinal products containing the active substances Ambisentan (ATC C02kx02), Bosentan (ATC C02KX01), Sildenafil (ATC G04BE03), Tadalafil (ATC G04BE08) and Macitentan (ATC C02KX04) pulmonary arterial hypertension (PAH) according to SPC valid As of the date of submission of offers.
LP to treat pulmonary arterial hypertension (PAH) XIII._Tadalafil
The subject of the public contract is the supply of medicinal products containing the active substances Tadalafil (ATC G04BE08) for the treatment of patients in approved pulmonary arterial hypertension (PAH) bids.
LP to treat pulmonary arterial hypertension (PAH) XIII_MACITENTAN
The subject of the public contract is the supply of medicinal products containing the active substances Macitentan (ATC C02KX04) for the treatment of patients in the approved indication of pulmonary arterial hypertension (PAH) according to the SPC valid on the date of bidding.
Lp to Treatment of pulmonary arterial hypertension (PAH) XIII_SILDENAFIL
The subject of the public contract is the supply of medicinal products containing the active substances Sildenafil (ATC G04BE03) for the treatment of patients in the approved indication of pulmonary arterial hypertension (PAH) according to the SPC valid on the date of tenders.
LP to treat lung Arterial Hypertension (PAH) XIII._BOSENTAN
The subject of the public contract is the supply of medicinal products containing active substances 02), Bosentan (ATC C02KX01) for the treatment of patients in the approved indication of pulmonary arterial hypertension (PAH) valid on the date of tenders.
LP to treat lung Arteri ...
Documents:

If you are registered member, kindly login to view full details of this tender notice:

Lp for the Treatment of Pulmonary Arterial Hypertension (Pah) Xiii. - Czech Tender

The INSTITUTE OF CLINICAL AND EXPERIMENTAL MEDICINE, a Government sector organization in Czech Republic, has announced a new tender for Lp for the Treatment of Pulmonary Arterial Hypertension (Pah) Xiii.. This tender is published on CzechTenders under CZT Ref No: 122492429 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-08-12.

The estimated tender value is CZK 24770000, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.